APC anti-mouse CX3CR1 [SA011F11] and 6 more items

The University of Virginia awarded a contract to BioLegend Inc., with an award date of June 13, 2026, for the procurement of specialized research reagents valued at $1,183.10. The contract, identified as A207_PO-0448965, involves the delivery of seven fluorescently-labeled monoclonal antibodies and one fixable viability kit to Melissa M. Kendall at the contracting organization in Virginia. These reagents include anti-mouse antibodies targeting CX3CR1, GATA3, CD3epsilon, CD19, and FOXP3, along with anti-mouse CD4 antibody and a Zombie Aqua Fixable Viability Kit, with individual unit prices ranging from $62.30 to $259.00.

The procured materials represent standard flow cytometry reagents commonly utilized in immunological and cellular research applications. All seven line items are designated for delivery to a single recipient and are characterized as individual unit purchases with no indication of recurring orders or extended contract duration. This award reflects a discrete procurement transaction by the University of Virginia's research operations for specialized laboratory supplies necessary to support ongoing scientific investigations.